Host-specific Interleukin-2-secreting Donor T-cell Precursors As Predictors of Acute Graft-versus-host Disease in Bone Marrow Transplantation Between HLA-identical Siblings
Overview
Authors
Affiliations
Background: Acute graft-versus-host disease (GVHD) is a serious complication of allogeneic bone marrow transplantation from an HLA-identical sibling. There is no practical test before transplantation that gives sufficient information to predict the degree of allogeneic reactivity between HLA-identical siblings.
Methods: We determined the frequency with which host-specific interleukin-2-secreting donor T-cell precursors occurred in 16 consecutive pairs of HLA-identical siblings before they underwent marrow grafting. The results were correlated with the development of acute GVHD after transplantation.
Results: High frequencies of host-specific T-cell precursors (> or = 1 per 100,000) were detectable before transplantation in eight donors whose siblings later had severe (grade II or III) acute GVHD. Among the donors to eight patients with mild (grade 0 or 1) acute GVHD, low frequencies (< 1 per 100,000) were found.
Conclusions: Analysis of the frequency of such cells before transplantation may be a useful predictor of severe acute GVHD in allogeneic bone marrow transplantation between HLA-identical siblings. It is possible that the patients at risk for serious acute GVHD after marrow grafting may benefit from some alternative form of immunosuppressive therapy.
The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease.
Bilinski J, Jasinski M, Basak G Biomedicines. 2022; 10(4).
PMID: 35453587 PMC: 9027325. DOI: 10.3390/biomedicines10040837.
Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M J Immunol Res. 2016; 2016:5601204.
PMID: 27965986 PMC: 5124677. DOI: 10.1155/2016/5601204.
Hirayama M, Azuma E, Komada Y Cells. 2014; 1(2):61-73.
PMID: 24710414 PMC: 3901092. DOI: 10.3390/cells1020061.
Veerapathran A, Pidala J, Beato F, Betts B, Kim J, Turner J Blood. 2013; 122(13):2251-61.
PMID: 23908471 PMC: 3785121. DOI: 10.1182/blood-2013-03-492397.
McGuirk J, Hao G, Hou W, Abhyankar S, Williams C, Yan W J Hematol Oncol. 2009; 2:17.
PMID: 19379511 PMC: 2678154. DOI: 10.1186/1756-8722-2-17.